Can Antimalarial Phytochemicals be a Possible Cure for COVID-19? Molecular Docking Studies of Some Phytochemicals to SARS-CoV-2 3C-like Protease
Authors:
- 1 February 2022
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Infectious Disorders - Drug Targets
- Vol. 22 (1) , 1-11
Abstract
Objective: To evaluate the efficacy of reported anti-malarial phytochemicals as lead compounds for possible drug development against COVID-19.Methods: An in silico approach was used in this study to determine through molecular docking the binding affinities and site of binding of these phytochemicals to the 3C-like protease of COVID-19 which is considered as the main protease of the virus.Results: A number of anti-malarial phytochemicals like apigenin-7-O-glucoside, decurvisine, luteolin- 7-O-glucoside, sargabolide J, and shizukaols A, B, F, and G showed predicted high binding energies with ΔG values of -8.0 kcal/mol or higher. Shizukaols F and B demonstrated the best binding energies of -9.5 and -9.8, respectively. The acridone alkaloid 5-hydroxynoracronycine also gave a predicted high binding energy of -7.9 kcal/mol.Conclusion: This is for the first time that decursivine and several shizukaols were reported as potential anti-viral agents. These compounds merit further studies to determine whether they can be effective drug candidates against COVID-19.Keywords
This publication has 38 references indexed in Scilit:
- Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against chikungunya virus in vero cellsJournal of Medical Virology, 2010
- Susceptibility ofPlasmodium falciparumIsolates to Doxycycline Is Associated withpftetQSequence Polymorphisms andpftetQandpfmdtCopy NumbersThe Journal of Infectious Diseases, 2010
- Plant-Derived Antimalarial Agents: New Leads and Efficient Phytomedicines. Part II. Non-Alkaloidal Natural ProductsMolecules, 2009
- The Antiviral Activities of Artemisinin and ArtesunateClinical Infectious Diseases, 2008
- Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycleAntiviral Research, 2007
- Combinatorial Computational Approaches to Identify Tetracycline Derivatives as Flavivirus InhibitorsPLOS ONE, 2007
- Mechanism of the Maturation Process of SARS-CoV 3CL ProteaseJournal of Biological Chemistry, 2005
- 3C-like Proteinase from SARS Coronavirus Catalyzes Substrate Hydrolysis by a General Base MechanismBiochemistry, 2004
- Antiviral Activity of Compounds Isolated From PlantsPharmaceutical Biology, 2003
- Primaquine Diphosphate: Inhibition of Newcastle Disease Virus ReplicationAntimicrobial Agents and Chemotherapy, 1974